Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 15 06:28 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 15 06:19 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 10 06:57 ET
Innate Pharma | 20-F: Registration statement / Annual report / Transition report
Apr 4 08:10 ET
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Mar 21 09:26 ET
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Mar 21 06:06 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 19 06:36 ET
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Mar 14 07:03 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 6 06:03 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 6 06:03 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 21 06:05 ET
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 6 17:09 ET
Innate Pharma | 424B5: Prospectus
Feb 6 17:03 ET
Innate Pharma | EFFECT: Others
Jan 17 00:00 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 12 00:00 ET
Innate Pharma | CORRESP: CORRESP
Jan 11 13:02 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 5 00:00 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 4 00:00 ET
Innate Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 4 00:00 ET
Innate Pharma | UPLOAD: Others
Dec 26, 2023 13:02 ET
No Data
No Data